XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

252 hedge funds and large institutions have $6.92B invested in Acceleron Pharma in 2020 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 82 increasing their positions, 85 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

4% less repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 85

19% less call options, than puts

Call options by funds: $19.6M | Put options by funds: $24.2M

Holders
252
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$19.6M
Puts
$24.2M
Net Calls
Net Calls Change

Top Buyers

1 +$48.8M
2 +$44.8M
3 +$42.3M
4
APM
Avidity Partners Management
Texas
+$38.3M
5
Invesco
Invesco
Georgia
+$25.8M

Top Sellers

1 -$149M
2 -$67.6M
3 -$46.2M
4
Ameriprise
Ameriprise
Minnesota
-$34.7M
5
KCM
Kingdon Capital Management
New York
-$29.3M
Name Holding Trade Value Shares
Change
Change in
Stake
151
$815K
152
$798K
153
$764K
154
$721K
155
$706K
156
$685K
157
$653K
158
$651K
159
$626K
160
$601K
161
$599K
162
$595K
163
$586K
164
$533K
165
$516K
166
$512K
167
$507K
168
$477K
169
$463K
170
$449K
171
$445K
172
$425K
173
$418K
174
$384K
175
$380K